Beitrag zur Physiologie des N. Vagus. I. Mitteilung : Uber die Funktion des N. vagus auf die Atmung

1) Der Gaswechsel und der Respirationsquotient des Einrecurrenskaninchens (Lungenvagusfreienkaninchens, vgl. II. Mitteilung) scheint fast keinen Unterschied im Vergleich mit den normalen und Kontrolltieren zu zeigen. Beim Versuch wurde der von Saeki (1931) am hiesigen Institut verbesserte Haldensche Apparat angewendet. Aus diesem Resultat gelangt der Verfasser zu dem Schluss, dass die Ausschaltung des Lungenvagus auf den Gaswechsel und den Respirationsquotienten fast keinen Einfluss ausubt. 2) Bei der Durchschneidungsmethode, die sicher den Lungenvagus auschaltet, tritt immer die typische Vagusatmung auf. 3) Was die Vagusatmung des Einrecurrenskaninchens nach der Operation betrifft, so kehrt wieder allmahlich im Verlauf der Zeit ersichtlich der normale Atmungszustand zuruck, aber durch eine leichte Storung, z. B. durch die Anlegung der Gasmaske, kann die typische Vagusatmung hervorgerufen werden. Um an wiedererholte Erhaltung des normalen Atmungszustandes nach der Ausschaltung des Lungenvagus zu denken, muss man voraussetzen, dass es anstatt des Lungenvagus noch einen anderen Regulations-mechanismus fur den normalen Atmungszustand geben; falls der Regulationsmechanismus durch eine leichte Storung gestort wird, tritt die Vagusatmung auf. Es ist sehr schwer zu denken, an welchem Ort und auf welche Weise die Regulation ausgeubt wird, aber der Verfasser vermutet, dass das Atemzentrum durch die centripetalen Impulse von uberangestrengtem Atemmuskel und Zwerchfell nach der Lungenvagusaus-schaltung wieder die regulatorische centrifugale Wirkung zum Atemmuskel und Zwerchfell sendet, wodurch der Regulationsmechanismus entsteht. 4) Die Abnahme der Atmungszahl nach der doppelseitigen Vagotomie am Halse kann nicht durch die Schafersche Glottislahmungstheorie oder Hymansche Aorten-Sinusnervenlahmungstheorie erklart werden, sondern durch die Ausschaltung des Lungen-vagus selbst. 5) Beim Einrecurrenskaninchen sieht man keine Apnoe beim Einblasen der Lunge. Es gilt als eine Bestatigung dafur, dass alle Vagusaste nach der Lunge

Bioproduction of the Recombinant Sweet Protein Thaumatin: Current State of the Art and Perspectives

There is currently a worldwide trend to reduce sugar consumption. This trend is mostly met by the use of artificial non-nutritive sweeteners. However, these sweeteners have also been proven to have adverse health effects such as dizziness, headaches, gastrointestinal issues, and mood changes for aspartame. One of the solutions lies in the commercialization of sweet proteins, which are not associated with adverse health effects. Of these proteins, thaumatin is one of the most studied and most promising alternatives for sugars and artificial sweeteners. Since the natural production of these proteins is often too expensive, biochemical production methods are currently under investigation. With these methods, recombinant DNA technology is used for the production of sweet proteins in a host organism. The most promising host known today is the methylotrophic yeast, Pichia pastoris. This yeast has a tightly regulated methanol-induced promotor, allowing a good control over the recombinant protein production. Great efforts have been undertaken for improving the yields and purities of thaumatin productions, but a further optimization is still desired. This review focuses on (i) the motivation for using and producing sweet proteins, (ii) the properties and history of thaumatin, (iii) the production of recombinant sweet proteins, and (iv) future possibilities for process optimization based on a systems biology approach

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Comparing design of experiments and optimal experimental design techniques for modelling the microbial growth rate under static environmental conditions

Building secondary models that describe the growth rate as a function of multiple environmental conditions is often very labour intensive and costly. As such, the current research aims to assist in decreasing the required experimental effort by studying the efficacy of both design of experiments (DOE) and optimal experimental designs (OED) techniques. This is the first research in predictive microbiology (i) to make a comparison of these techniques based on the (relative) model prediction uncertainty of the obtained models and (ii) to compare OED criteria for the design of experiments with static (instead of dynamic) environmental conditions. A comparison of the DOE techniques demonstrated that the inscribed central composite design and full factorial design were most suitable. Five conventional and two tailor made OED criteria were tested. The commonly used D-criterion performed best out of the conventional designs and almost equally well as the best of the dedicated criteria. Moreover, the modelling results of the D-criterion were less dependent on the experimental variability and differences in the microbial response than the two selected DOE techniques. Finally, it was proven that solving the optimisation of the D-criterion can be made more efficient by considering the sensitivities of the growth rate relative to its value as Jacobian matrix instead of the sensitivities of the cell density measurements.status: publishe

A tutorial on uncertainty propagation techniques for predictive microbiology models: A critical analysis of state-of-the-art techniques

Building mathematical models in predictive microbiology is a data driven science. As such, the experimental data (and its uncertainty) has an influence on the final predictions and even on the calculation of the model prediction uncertainty. Therefore, the current research studies the influence of both the parameter estimation and uncertainty propagation method on the calculation of the model prediction uncertainty. The study is intended as well as a tutorial to uncertainty propagation techniques for researchers in (predictive) microbiology. To this end, an in silico case study was applied in which the effect of temperature on the microbial growth rate was modelled and used to make simulations for a temperature profile that is characterised by variability. The comparison of the parameter estimation methods demonstrated that the one-step method yields more accurate and precise calculations of the model prediction uncertainty than the two-step method. Four uncertainty propagation methods were assessed. The current work assesses the applicability of these techniques by considering the effect of experimental uncertainty and model input uncertainty. The linear approximation was demonstrated not always to provide reliable results. The Monte Carlo method was computationally very intensive, compared to its competitors. Polynomial chaos expansion was computationally efficient and accurate but is relatively complex to implement. Finally, the sigma point method was preferred as it is (i) computationally efficient, (ii) robust with respect to experimental uncertainty and (iii) easily implemented.status: publishe

Dynamic optimization of biological networks under parametric uncertainty

Background: Micro-organisms play an important role in various industrial sectors (including biochemical, food and pharmaceutical industries). A profound insight in the biochemical reactions inside micro-organisms enables an improved biochemical process control. Biological networks are an important tool in systems biology for incorporating microscopic level knowledge. Biochemical processes are typically dynamic and the cells have often more than one objective which are typically conflicting, e.g., minimising the energy consumption while maximizing the production of a specific metabolite. Therefore multi-objective optimization is needed to compute trade-offs between those conflicting objectives. In model-based optimization, one of the inherent problems is the presence of uncertainty. In biological processes, this uncertainty can be present due to, e.g., inherent biological variability. Not taking this uncertainty into account, possibly leads to the violation of constraints and erroneous estimates of the actual objective function(s). To account for the variance in model predictions and compute a prediction interval, this uncertainty should be taken into account during process optimization. This leads to a challenging optimization problem under uncertainty, which requires a robustified solution. Results: Three techniques for uncertainty propagation: linearization, sigma points and polynomial chaos expansion, are compared for the dynamic optimization of biological networks under parametric uncertainty. These approaches are compared in two case studies: (i) a three-step linear pathway model in which the accumulation of intermediate metabolites has to be minimized and (ii) a glycolysis inspired network model in which a multiobjective optimization problem is considered, being the minimization of the enzymatic cost and the minimization of the end time before reaching a minimum extracellular metabolite concentration. A Monte Carlo simulation procedure has been applied for the assessment of the constraint violations. For the multi-objective case study one Pareto point has been considered for the assessment of the constraint violations. However, this analysis can be performed for any Pareto point. Conclusions: The different uncertainty propagation strategies each offer a robustified solution under parametric uncertainty. When making the trade-off between computation time and the robustness of the obtained profiles, the sigma points and polynomial chaos expansion strategies score better in reducing the percentage of constraint violations. This has been investigated for a normal and a uniform parametric uncertainty distribution. The polynomial chaos expansion approach allows to directly take prior knowledge of the parametric uncertainty distribution into account.status: publishe